FuGENE HD转染试剂说明书

合集下载

fugene 4k 转染试剂 中文说明书

fugene 4k 转染试剂 中文说明书

2022版 CTM694原英文技术手册TM694中 文 说 明 书适用产品目录号:E5911和E5912FuGENE ®4K TransfectionReagent普洛麦格(北京)生物技术有限公司Promega (Beijing) Biotech Co., Ltd 地址:北京市东城区北三环东路36号环球贸易中心B座907-909电话:************网址:技术支持电话:400 810 8133技术支持邮箱:*************************CTM 6942022制作1所有技术文献的英文原版均可在/ protocols 获得。

请访问该网址以确定您使用的说明书是否为最新版本。

如果您在使用该试剂盒时有任何问题,请与Promega 北京技术服务部联系。

电子邮箱:*************************1. 描述 (2)2. 产品组分和储存条件 (2)3. 一般注意事项 (2)3. A. 转染试剂与DNA的比例 (3)3. B. DNA (3)3. C. 时间 (3)3. D. 血清 (3)3. E. 细胞培养条件 (3)3. F. 稳定转染 (3)4. 推荐操作步骤 (4)4. A. 细胞铺板 (5)4. B. FuGENE® 4K Transfection Reagent准备 (5)4. C. 一般转染操作步骤 (6)4. D. 稳定转染操作步骤 (8)4. E. 转染优化 (9)4. F. 报告基因活性和细胞健康的多重检测方案 (11)5. 疑难解答 (12)FuGENE® 4K Transfection Reagent普洛麦格(北京)生物技术有限公司Promega (Beijing) Biotech Co., Ltd 地址:北京市东城区北三环东路36号环球贸易中心B座907-909电话:************网址:技术支持电话:400 810 8133技术支持邮箱:*************************CTM 6942022制作21. 描述FuGENE® 4K Transfection Reagent是一个多组分,非脂质体试剂,用于将DNA高效、低毒地转染至多种哺乳动物细胞系中,无需在加入试剂-DNA复合物后更换培养基。

上海杰美基因医药 GENMED 重组腺病毒转染试剂盒产品说明书(中文版)

上海杰美基因医药 GENMED 重组腺病毒转染试剂盒产品说明书(中文版)

上海杰美基因医药科技有限公司杰美品牌大师品质GMS60036 v.A GENMED重组腺病毒转染试剂盒产品说明书(中文版)主要用途GENMED重组腺病毒转染试剂是一种旨在通过强烈的阳离子脂质体介导载体,帮助腺病毒基因组质粒或腺病毒载体穿梭质粒DNA轻易通过病毒包装细胞的权威而经典的技术方法。

该技术由大师级科学家精心研制、成功实验证明的。

其适用于各种病毒质粒DNA(例如pJM17或pBHG10等)转入多种类型的贴壁型病毒包装培养细胞系(例如人胚胎视网膜911细胞或人胚肾293细胞等)。

可以被用于稳定转染或暂态转染。

产品严格无菌,即到即用,无核酶污染,配比优化,操作简捷,性能稳定,转染效率明显。

技术背景LipofusinX为带有精胺基团强负电性的脂质体介导载体,其基团具有超强的穿膜能力,血清干扰因素无损于携带外源性DNA高效进入细胞内。

产品内容GENMED清理液(Reagent A) 毫升GENMED转染液(Reagent B) 微升GENMED强化液(Reagent C) 微升GENMED保存液(Reagent D) 毫升产品说明书 1份保存方式保存在4℃冰箱里,有效保证6月用户自备质粒DNA:用于转染的目标DNA病毒包装细胞(例如911细胞或293细胞等):用于目标DNA转染的宿主细胞1.5毫升离心管:用于转染液和DNA操作的容器胰蛋白酶乙二胺四乙酸混合液(GMS12024):用于细胞脱离完全细胞培养液(GMS12052):用于转染后的细胞培养实验步骤转染实验开始前,移取微升GENMED清理液(Reagent A)到无菌的毫升离心管,然后加入微升GENMED转染液(Reagent B),再加入微升GENMED强化液(Reagent C),用微升枪头轻轻上下抽吸混匀,成为转染工作液。

然后进行下列操作。

1.准备个cm2细胞培养瓶里的病毒包装细胞(例如911细胞或293细胞等)2.在转染前小时,用胰蛋白酶乙二胺四乙酸混合液脱离细胞一次3.细胞铺满率达%(细胞)4.移取微升GENMED清理液(Reagent A)到无菌的毫升离心管5.方法一:(双质粒共转染)分别加入微升用户需转染的腺病毒载体穿梭质粒DNA(微克)和微升腺病毒基因组质粒DNA(微克),用微升枪头轻轻上下抽吸混匀方法二:(单一线性质粒转染)加入微升用户需转染的重组腺病毒线性载体DNA(微克),用微升枪头轻轻上下抽吸混匀6.用微升枪头一滴一滴缓慢加入DNA混匀物到转染工作液里,再用枪头轻轻上下抽吸混匀7.混匀后,在室温下静置分钟,期间轻轻混匀数次8.同时小心抽掉细胞培养瓶里的培养液9.轻轻加入毫升℃预热的GENMED清理液(Reagent A)10.即刻小心抽掉GENMED清理液(Reagent A)11.重复实验步骤和一次12.轻轻加入毫升GENMED清理液(Reagent A)到培养瓶里13.轻轻混匀含有DNA的转染工作液,即刻轻轻缓慢加入微升到细胞培养瓶里14.轻轻摇动细胞培养瓶,使其混匀15.放进℃细胞培养箱,孵育小时(注意:参见注意事项9)16.小心抽掉含有DNA的转染工作液(注意:参见注意事项10和11)17.加入毫升用户自备的完全细胞培养液18.放进℃细胞培养箱,孵育过夜19.以后每隔天小心抽掉细胞培养瓶里的培养液20.小心加入至毫升用户自备的完全细胞培养液21.转染后天,刮下细胞培养瓶里的细胞22.移入到毫升锥形离心管23.放进台式离心机离心分钟,速度为g24.小心抽去上清液25.加入毫升GENMED保存液(Reagent D)26.放进℃冰箱里保存或即刻进行病毒上清制备以及后续感染注意事项1.本产品为10次操作量2.整个操作须无菌操作3.操作时,须戴手套4.注意病毒操作安全5.操作时使用的枪头须使用带滤芯的枪头6.建议使用高度纯化且无内毒素的载体DNA7.建议一次操作,同时进行5个以上25cm2细胞培养瓶的转染,确保足够获得重组腺病毒量8.根据用户实际情况,建议使用空载体对照或报告基因标记对照9.孵育时建议将培养瓶密封,以防或避免转染工作液蒸发10.更换液体时,须小心,以防细胞松动或脱落11.如果转染孵育后,出现较多细胞松动和脱落,直接加入5毫升用户自备的完全细胞培养液,继续孵育24小时后,进行更换12.通常转染后2周内,不会出现明显的空斑形成或细胞病理效应(CPE)13.本产品提供的成分配比优化14.如果转染不理想,可以适当调整转染液、强化液和DNA用量15.本公司提供系列腺病毒试剂产品和外包服务质量标准1.本产品经鉴定性能长期稳定2.本产品经鉴定转染效率高使用承诺杰美基因秉着“信誉至上、客户满意、质量承诺”的宗旨为我们的用户提供优质产品和服务。

FuGENE 转染流程

FuGENE 转染流程

FuGENE HD真核细胞转染流程FuGENE HD Transfection Reagent Quick Protocol.pdfFuGENE HD Transfection Reagent.pdf1.细胞和质粒的准备①将约5-10×105A549细胞接种于6孔细胞板中,用含10%小牛血清的F-12k培养过夜,约60%~80%铺满时用于转染。

注:一般荧光试验细胞稀一点为宜;WB试验细胞密一点为宜②转染时所用质粒均用转染专用质粒抽提试剂盒无菌提取,抽提后测定其浓度和纯度,浓度在0.1μg/μL以上且纯度在1.8±0.5 (OD260/OD280)的质粒用于转染,质粒提取的具体步骤按说明书提供的方法进行。

(注:质粒浓度测定未必可行,需同时进行酶切和PCR鉴定方可。

)③按照转染剂量,计算质粒使用浓度2.转染流程注:由于不同转染试剂对质粒大小、性质、转染量、细胞的种类有很强的特异性,必须谨慎选择转染试剂。

以多次转染成功使用的转染试剂为佳。

①将培养板中的上清弃去,用细胞用无抗无血清F12K洗涤三次后,每孔加入800ul 无抗无血清F12K。

②取出FuGENE HD转染试剂,使其温度上升到室温。

③计算好质粒、转染试剂、以及无抗无血清F12K的量,最终液体总量为100 ul。

准备好无菌指形管,按计算结果加入90-98ul的无抗无血清F12K,加入2ug 质粒,振荡器混匀;随后加入6ul FuGENE HD转染试剂,立即震荡混匀(转染试剂加入时不能沾到管壁上!)④室温静置7-12分钟后,将质粒:转染试剂混合液均匀滴加在细胞平板孔中,吹打混匀或者震荡混匀。

放入37℃培养箱孵育。

⑤转染后2 h后加入含有血清的F12K,使血清终浓度达到1-4%,上清总量达到1.5-2 ml。

细胞平板放入37℃培养箱培养24-48h。

⑥转染后特定时间点,用4℃预冷的PBS漂洗细胞3次,加入含有PMSF的Western细胞裂解液冰上裂解15min。

EndoFectinTM-Max 转染试剂用户手册说明书

EndoFectinTM-Max 转染试剂用户手册说明书

EndoFectin TM -Max 转染试剂高效转染核酸到哺乳动物细胞产品编号:EF003 / EF004 / EF003T 包装规格:1 mL / 3 mL / 100 μL储存条件:4℃~8℃密闭保存,可保持稳定至少12个月,常温运输。

产品概述EndoFectin TM -Max 转染试剂是以脂质体转染为原理的转染试剂,它能与核酸形成复合物,并使该复合物进入哺乳动物细胞。

EndoFectin TM -Max 转染试剂广泛适用于常见细胞系,如HEK-293、HEK293T 、CHO-K1、Hep G2、Hela 、MCF-7、NIH/3T3和A549等。

即使在有血清存在的情况下,该试剂仍能高效将核酸导入细胞。

GeneCopoeia 公司提供的EndoFectin TM -Max 转染试剂具有如下优点: y 转染效率更优良 y 细胞毒性低y 适用于多种细胞系的转染操作,操作简便y 与含血清的培养基相兼容,转染前不需去除细胞培养液或血清,转染后不需清洗细胞质量控制每批次EndoFectin TM -Max 转染试剂均经过转染测试。

将eGFP 表达质粒(GeneCopoeia Cat.No. EX-EGFP-M02)用EndoFectin TM -Max 转染试剂转入亚融合状态的HEK-293细胞,转染24小时后,超过95%的细胞表达eGFP 。

注意事项使用高质量的质粒:请务必使用高质量的转染级无内毒素质粒。

可通过260 nm 光吸收测定DNA 浓度,并以260 nm / 280 nm 比值确定DNA 纯度(比值应在1.8~2.0的范围内)。

如有可能,请通过琼脂糖凝胶电泳检测质粒的完整性。

保证细胞状态:请使用适当保存和经常传代的健康细胞,并确保培养基无细菌、真菌或支原体污染。

如果细胞是近期复苏的液氮冻存细胞,请在转染前至少传代两次。

实验材料y EndoFectin TM -Max 转染试剂、含目的基因的DNA 质粒y 无蛋白细胞培养液(如Opti-MEM I TM ,来自Life Technologies . 货号:31985-088) y 培养至70~80%汇合度的目的细胞条件摸索在进行正式转染前,推荐以EndoFectin TM -Max 转染试剂摸索目的细胞的最佳转染条件。

HighGene plus Transfection reagent 说明书

HighGene plus Transfection reagent 说明书

HighGene plus Transfection reagent说明书货号:RM09014P规格:1mL,10mL◆产品描述HighGene plus Transfection reagent细胞转染试剂是一种新型的混合型高分子聚合物转染试剂。

它可以与核酸(包括质粒、siRNA、寡聚核苷酸)相互作用形成一种复合物将核酸转运到真核细胞内,适用于大部分真核细胞的细胞转染。

◆产品特点1、适用于多种细胞类型和培养板。

2、高转染效率、批次稳定重复性好、操作简单。

3、转染过程不受血清和抗生素的影响。

◆保存条件-20℃保存,24个月有效。

◆操作说明1、贴壁细胞转染(以293T细胞为例)(1)第一天,将293T细胞接种到6孔板中,细胞密度控制在70%-90%为宜;注:根据实验需求,可以选择不同的细胞培养装置,细胞接种数量和所需培养液体积详见附表1(2)第二天,先取4μg质粒加入到200μL无血清DMEM基础培养基离心管中,吹打混合均匀,然后加入8μL HighGene plus转染试剂,吹打混合;注:MEM、1640、F12等基础培养基均可用于HighGene plus转染试剂的溶剂,不同的细胞培养装置所需质粒的量和HighGene plus转染试剂剂量详见附表2(3)将200μL质粒/HighGene plus转染试剂复合物均匀滴加到6孔细胞培养板孔中,轻轻晃动细胞培养板使其均匀分布;注:6孔板中为完全培养基,轻轻晃动细胞培养板即可,切勿剧烈摇动细胞培养板,以免细胞脱落漂浮!(4)细胞转染4-6h后,半量更换新鲜完全培养基;注:半量换液时,吸弃一半原有完全培养基,补加一半新鲜完全培养基(5)细胞转染24-48h后,即可使用适当方式进行检测,如RT-PCR、Western、ELISA、报告基因等,或加入相应筛选药物(G418或Puromycin)可获得稳定细胞株。

2、悬浮细胞转染(以HEK293F细胞为例)(1)第一天,在125mL摇瓶中接种30mL密度为1×106个/mL HEK293F悬浮细胞;(2)第二天,先取30μg质粒加入到3mL无血清DMEM基础培养基离心管中,吹打混合均匀,然后加入60μL HighGene plus转染试剂,吹打混合均匀;(3)将3mL质粒/HighGene plus转染试剂复合物均匀滴加到30mL体积HEK293F悬浮细胞的125mL摇瓶中,轻轻摇动摇瓶使其混合均匀;(4)细胞转染3-5天后,根据蛋白表达的情况(胞内表达或分泌表达),收集细胞或细胞培养上清,进行后续蛋白纯化操作。

覆盖更宽广的领域转染试剂

覆盖更宽广的领域转染试剂

覆盖更宽广的领域转染试剂Roche的FuGENE 6 转染试剂低毒高效、使用方便,应用细胞株已达500多种,可谓有口皆碑——即使近10年来Roche在试剂领域甚为低调甚少宣传,一支独秀的FuGENE 6 依然让Roche保持在转染领域数一数二的地位。

经过10年的沉积,如今Roche新推出FuGENE HD转染试剂,再度将转染推向一个更高的层次——正在预备实验的你,对转染的最高期望是什么呢?——高效转染?毫无疑问!不单转染效率要高,适用细胞范围更要广:FuGENE HD 完全满足你的期望——即使RAW 264.7, MCF-7, PC-3, MA-10, HepG2, SH-SY5Y, A7r5, STO, SCC-61, SQ20B, T98G等等其他转染试剂难转染的哺乳动物细胞株,FuGENE HD 一样能给你满意的结果!RealTime ready 智力大冲浪!答对5题,即获赠美国傲仕优质保温杯!独特的多用途转染试剂——无论是哺乳动物细胞转染,或者是昆虫细胞转染,FuGENE HD 都同样胜任!如果你的实验同时涉及这两类不同类型的细胞,你再也不需要另外购买、另外设计另一套转染方案了!——对细胞更低毒性?当然要啦!可不要象脂质体转染试剂那样转染一次死伤大半,残存的转染细胞形态尽失。

FuGENE HD 更低的细胞毒性,不单使得转染程序简便,更令大部分转染细胞保持正常的细胞形态,伤害越小当然效果越好!——转染得到更高的蛋白表达?绝对要的!转染效率高但表达效率低那有啥意思?!转染,自然就希望得到更好的表达。

FuGENE HD 更优于其他转染试剂,特别在于它能令细胞表达水平更高,表达时间更长!特别是在HeLa, NIH/3T3, COS-1, COS-7, CHO-K1, CHO-S, Hep G2, H EK-293, MCF-7,昆虫细胞株High Five,Sf9等细胞中表达量显著提高——应用范围更广?那更好啦!FuGENE HD 非脂质体配方不含动物来源成分,令实验适用范围更广,在特殊实验需要时你也不必另外购买不含动物来源成分的转染试剂,一支搞定。

qBac-III Bacmid转染试剂说明书

qBac-III Bacmid转染试剂说明书

Bacmid qBac-III 简要手册V1.4.32021.05本产品包含qBac-III(Bacmid DNA,每次转染使用40ng [5µL],浓度8ng/µL)Control plasmid*(阳性对照转移载体质粒DNA,每次转染使用300ng [3µL],浓度100ng/µL)使用者需要准备1.转染试剂2.昆虫细胞培养基(加100UI/ml 氨苄青霉素和100UI/ml 链霉素)3.六孔板或35mm 细胞培养皿,每孔(皿)铺1x106个Sf9细胞(2mL)4.带有目的基因片段的转移载体质粒**(每次转染需要300ng)程序***(以Promega FuGENE HD Transfection Reagent 转染试剂为例,其他转染试剂请参照具体使用说明)A)准备转染DNA 混合物1.向无菌的1.5mL 离心管中加入95µL ddH 2O(或无血清培养基),再向离心管中加入5µL Promega FuGENE HD Transfection Reagent 转染试剂,充分混匀。

2.向无菌的1.5mL 离心管中加入92µL ddH 2O(或无血清培养基),再向离心管中加入5µL Bacmid DNA,再向离心管中加入3µL 转移载体质粒DNA,充分混匀。

3.将(1)中溶液加入(2)中,充分混匀,室温静置20-30min。

B)将DNA 混合物加到细胞中1.将DNA 混合物逐滴均匀加入细胞培养皿中。

2.放置28℃培养箱中静置培养4-6天。

C)收获P0代病毒1.收集培养皿中的培养基(上清),4℃避光保存。

此即为P0代病毒。

D)表达蛋白1.用20-200µL P0代病毒加到铺好细胞的六孔板的一个孔中,28℃静置培养4天,收集培养皿中的培养基(上清),300X g 离心5min 移除细胞碎片,获得P1代病毒,测定滴度(方法自选)。

各种转染试剂中文说明

各种转染试剂中文说明

FuGENE6(Roche)转染步骤:转染前一天将细胞分至培养板,转染当天细胞应50-80%融合。

将细胞以1-3×105/2ml接种于6孔板后孵育过夜将达到如此密度。

将FuGENE6 Reagent在室温孵育10-15分钟。

使用之前将FuGENE6颠倒混匀一下。

1.在PCR管中加入不含血清和双抗的营养液以稀释FuGENE6,直至总体积到100ul。

2.将3-6ul FuGENE6 Reagent直接加入营养液,轻弹管壁混合。

3.加入1-2ug的DNA溶液(0.02-2.0ug/ul),轻弹管壁混合。

4.室温孵育20分钟。

5.将6孔板中的旧营养液吸出,加入约1ml不含血清和双抗的营养液洗涤一次,再加入2ml不含血清和双抗的营养液。

6.将转染复合物加入细胞,混匀使之均匀分布。

7.3-8小时后,加入血清或换成含血清的营养液。

Lipofectamine 2000(Invitrogen)转染试剂转染步骤(6孔板):1.转染前一天,胰酶消化细胞并计数,细胞铺板,使其在转染日密度为90-95%。

细胞铺板在2ml含血清,不含抗生素的正常生长的培养基中。

2.对于每孔细胞,使用250ul无血清培养基(如OPTI-MEM I培养基)稀释4.0ugDNA,轻轻混匀。

3.使用前将Lipofectamine 2000转染试剂轻轻混匀,用250ul无血清培养基(如OPTI-MEM I培养基)稀释10ul Lipofectamine 2000转染试剂,轻轻混匀。

Lipofectamine 2000稀释后,在5分钟内同稀释的DNA混合(<30分钟)。

NOTE:若使用DMEM培养基,则需在5分钟内同稀释的DNA混合。

4.混合稀释的DNA(第二步)和稀释的Lipofectamine 2000(第三步)。

室温放置20分钟。

5.(optional)将6孔板中的旧营养液吸出,用无血清培养基清洗两次。

加入2ml无血清配养基。

FuGENE6转染试剂中文操作说明

FuGENE6转染试剂中文操作说明

FuGENE6转染试剂中文操作说明FuGENE®6原是Roche公司的旗舰转染产品,如今已归为Promega公司旗下。

它是一种非脂质体转染试剂,广泛适用于高效转染各种细胞系,且细胞毒性非常低。

由于使用该转染试剂转染时不要求去除血清或培养液,并且转染后也不要求换液去除,因而使用起来非常方便。

配方和包装:FuGENE® 6是由脂质与其他组分按照合适比例混合,溶于80%乙醇而成。

试剂通过0.1μm的滤器过滤并分装至小玻璃瓶。

注意事项:转染前须保证FuGENE® 6温度已经达到室温,使用前须上下颠倒数次进行简单混匀。

建议使用标准的24孔板作为FuGENE®6转染试剂的支架。

请不要将原瓶中的FuGENE®6进行分装。

尽可能减少FuGENE®6原液与塑料制品的表面接触。

不要使用硅化的枪头或离心管。

在稀释FuGENE® 6时,请务必保证将FuGENE® 6直接混入培养基,而不要接触到离心管。

(研小弟注:还要防挥发,毕竟溶于80%乙醇,所以也不宜分装)抗生素的使用:在细胞系的常规培养时可以使用抗生素。

但在转染时抗生素的存在可能会影响转染的效率以及转染细胞的整体健康。

除非之前已经在转染细胞中测试过,否则我们不推荐在转染培养液中添加抗生素。

转染步骤:以下是一个简易的中文转染步骤示意图具体的转染步骤包括:•细胞的接种在转染前一天接种细胞,保证在转染时细胞的汇合度在50-80%,悬浮细胞可以在转染当天接种。

通常96孔板中每个孔适宜接种100μl 含1-2×104的贴壁细胞或2×104到1×105的悬浮细胞。

对于其他规格的培养板的推荐细胞数,可参考下表(数据针对Corning公司生产的培养板)。

96-well 0.32 1×24-well 1.88 5×12-well 3.83 10×6-well 9.4 30×35mm 8 25×60mm 21 65×100mm 55 170וFuGENE® 6转染试剂的准备1.转染前保证FuGENE® 6温度已经达到室温2.使用前上下颠倒数次进行简单混匀。

Glosensor cAMP检测实验手册说明书

Glosensor cAMP检测实验手册说明书

检测实验主要通过cAMP结合域融合到野生型的萤火虫荧光素酶的N-和C-末端来实现。

cAMP缺结合域的荧光素酶处于未激活cAMP结合域构象发生变化处于激活状态引起化学发光信号增加,从而被FLIPR Tetra系统检测到。

FLIPR Tetra 系统:•超灵敏ICCD相机既可以对化学发光检测,同时也可以检测荧光信号•活细胞中动态的cAMP冷光信号检测通过FLIPR Tetra系统的超灵敏ICCD相机来实现•实验通量: 96-, 384-和1536-孔记录板规格,可很方便与自动化设备整合材料cAMP细胞系和质粒•GloSensor cAMP HEK 293 stable cell line (Promega Corporation, Cat. #E1261)•GloSensor cAMP 23F CHO K1-stable cell line (Promega R&D)•Rat Y2R/GloSensor cAMP 23F CHO-K1 double stable cell line (Promega R&D)•GloSensor cAMP assay plasmid pGlosensor-22FcAMP (Promega, Cat. #E2301)•Dopamine D4 stable HEK 293T cell line (Multispan Inc., Cat.#C1338)细胞培养试剂•HEK 293 cell growth medium: 90% DMEM (Life Technologies, Cat. #11995- 065), 10% FBS (Hyclone, Cat. #SH.30071), 200μg/mL hygromycin B (Sigma, Cat. #H3274)•GloSensor cAMP-23F CHO-K1 cell growth medium: 90% F-12Medium (LifeTechnologies, Cat. #11765), 10% FBS, and 200mg/mL hygromycin B)•Glo Sensor cAMP-23F/Y2R CHO-K1 double stable cell growth medium: 90% F-12 Medium (Life Technologies, Cat. #11765), 10% FBS, and 200 μg/mL hy-gromycin B), and 500 μg/mL G418 (Life Technologies, Cat. #10131027)实验试剂•Plating medium: 90% CO2-independent medium (Life Technologies, Cat.#18045), 10% FBS•HEPES buffer: Re-suspend HEPES in deionized water to 10 mM; adjust pH to7.5 using KOH•GloSensor cAMP Reagent stock solution: Re-suspend 250 mg GloSensor cAMP Reagent (Promega, Cat. #E1291) in 8.17 mL of HEPES buffer; store at -70°C in single-use aliquots•平衡溶液:种植液(见上)和2%或5% GloSensor cAMP试剂;需根据具体实验情况进行优化•化合物:(-)异丙肾上腺素(Sigma, Cat. #I6504); 羟甲叔丁肾上腺素(Sigma, Cat. #S8260); 普萘洛尔(Sigma, Cat. #P0884); 吲哚洛尔(Sigma, Cat. #P0778); 阿普洛尔(Sigma, Cat. #A8676); 多巴胺(Sigma, Cat. # H8502). Peptide YY(3-36), (Tocris Cat. #1618); 所有化合物母液均配置为10 mM ,添加HBSS + 20 mM HEPES做进一步的稀释方法稳定的GloSensor cAMP 细胞系实验方法Step 1. 细胞在384孔黑壁底透的细胞板(Corning, Cat.#3712)中过夜培养。

转染试剂使用说明书

转染试剂使用说明书

2. 3).
配制转染工作液: ( 6 孔板或 35 mm 平皿, 2 ml 培养液) 取 5~8μ g DNA (起始用量 5μ g) ,加入稀释液中至总体积为 100μ l,轻轻混匀,室 温放置。
4).
先将 GenFectin TM 涡旋振荡混匀。取 GenFectinTM 1~4μl(起始用量 2μl,) ,加入稀 释液中至总体积为 100μl,轻轻混匀,室温放置 5 分钟。
5).
将稀释的 GenFectinTM 逐滴加入稀释的 DNA 溶液中,轻轻混匀,所得的转染工作 液在室温放置 15 分钟。
6).
将转染工作液轻轻混匀,逐滴加入 2 ml 培养液中,轻轻混匀培养液,置 37℃,5% CO 2 培养。
3. 细胞后续处理: 7). 24~48 小时后,观察或收取细胞。
-4-
8).
稳定转染时,于转染后 24~48 小时消化细胞分至 3~5 个培养皿中,加适当浓度的 相应抗生素(如 G418)筛选。

建议的起始转染条件 : 培养容器
96 孔板 24 孔板 6 孔板 35mm 培养皿 60mm 培养皿
转染前一天 接种细胞数
1-1.510 个 0.5-1 10 个 2-4 10 个 2-4 10 个 4-6 105 个
5 5 5 4
转染时 培养液体积
0.1 ml 0.5 ml 2 ml 2 ml 4 ml
DNA 用量 与稀释后体积
0.25 μg 1.25 μg 5 μg 5 μg 10 μg 5 μl 25 μl 100 μl 100 μl 200 μl
GenFectin 量 与稀释后体积
0.1 μl 0.5 μl 2 μl 2 μl 4 μl 5 μl 25 μl 100 μl 100 μl 200 μl

FuGENE HD转染试剂操作指导说明书

FuGENE HD转染试剂操作指导说明书

FuGENE ®HD 转染试剂简明操作指导注意:这是节选操作步骤,详细英文说明书TM328见/protocols/I. 说明:FuGENE ®HD 转染试剂采用专利的脂质混合体配方,提供了一个高效、低毒的转染方法;不含任何人体或其他动物来源的组分,转染前细胞不用去血清培养,转染后不用更换培养基,最大限度的减少对细胞的外源性干扰;操作方便,简单易用,尽可能节省研究者宝贵的实验时间。

要获得最高的转染效率,通常情况下需要优化质粒与转染试剂的配比,尤其对于难转染细胞,优化后转染效率可能会有明显提升。

但对于FuGENE ®HD 的首次使用者,可首先参考下面的表格,表格中列出的细胞已经过Promega 公司验证,并提供已优化好的操作步骤,可直接用FuGENE ®HD 进行成功的转染。

适用产品目录号:E2311、E2312800 810 8133NIH3T3小鼠成纤维细胞U937人组织细胞淋巴瘤细胞HEK293人胚胎肾细胞STSAR90人肉骨瘤细胞CHO-K1中国仓鼠卵巢细胞AGS 人胃腺癌细胞CHO-S 中国仓鼠卵巢细胞(悬浮细胞)BHK-21仓鼠肾成纤维细胞SNU-16人胃癌细胞Caco-2人结肠腺癌细胞A-375人黑色素瘤细胞Caki-1人肾透明细胞癌皮肤转移细胞T98G 人恶性胶质瘤细胞Capan-1人胰腺癌细胞HeLa 人宫颈癌细胞H4人神经胶质瘤细胞HepG2人肝癌细胞HSMM 人骨骼肌成肌细胞(原代细胞)High Five TM 粉纹夜蛾细胞(昆虫细胞)NCI-N87人胃癌细胞MCF-7人乳腺癌细胞Panc-1人胰腺癌细胞mES 小鼠胚胎干细胞(干细胞)SK MEL-28人黑色素瘤细胞hES 人胚胎干细胞(干细胞)SK-OV-3人卵巢癌细胞PC3人前列腺癌细胞T-24人膀胱癌细胞RAW264.7小鼠巨噬细胞T-84人结肠癌细胞SCC61人头颈鳞癌细胞U-87 MG 人脑星形胶质母细胞瘤细胞SQ20B 人头颈鳞癌细胞A549人非小细胞肺癌细胞STO 小鼠胚胎成纤维细胞DMS 53人小细胞肺癌细胞U-2 OS 人肉骨瘤细胞T47D 人乳腺管癌细胞COS-7非洲绿猴SV40转化的肾细胞Jurkat 人T 淋巴细胞白血病细胞(悬浮细胞)293F人胚肾细胞Huh7人肝癌细胞已经过Promega 公司验证的、可用FuGENE ®HD 进行成功转染的细胞:以上表格中所列的细胞种类,都可以使用在线工具/resources/tools/fugene-hd-protocol-database/检索专用的操作步骤。

FuGENE 6 转染步骤

FuGENE 6 转染步骤

配方和包装:FuGENE® 6是由脂质与其他组分按照合适比例混合,溶于80%乙醇而成。

试剂通过0.1μm的滤器过滤并分装至小玻璃瓶。

注意事项:转染前须保证FuGENE®6温度已经达到室温,使用前须上下颠倒数次进行简单混匀。

建议使用标准的24孔板作为FuGENE® 6转染试剂的支架。

请不要将原瓶中的FuGENE®6进行分装。

尽可能减少FuGENE®6原液与塑料制品的表面接触。

不要使用硅化的枪头或离心管。

在稀释FuGENE® 6时,请务必保证将FuGENE® 6直接混入培养基,而不要接触到离心管。

(研小弟注:还要防挥发,毕竟溶于80%乙醇,所以也不宜分装)抗生素的使用:在细胞系的常规培养时可以使用抗生素。

但在转染时抗生素的存在可能会影响转染的效率以及转染细胞的整体健康。

除非之前已经在转染细胞中测试过,否则我们不推荐在转染培养液中添加抗生素。

转染步骤:以下是一个简易的中文转染步骤示意图具体的转染步骤包括:•细胞的接种在转染前一天接种细胞,保证在转染时细胞的汇合度在50-80%,悬浮细胞可以在转染当天接种。

通常96孔板中每个孔适宜接种100μl含1-2×104的贴壁细胞或2×104到1×105的悬浮细胞。

对于其他规格的培养板的推荐细胞数,可参考下表(数据针对Corning公司生产的培养板)。

96-well 0.32 1×24-well 1.88 5×12-well 3.83 10×6-well 9.4 30×35mm 8 25×60mm 21 65×100mm 55 170וFuGENE® 6转染试剂的准备1.转染前保证FuGENE® 6温度已经达到室温2.使用前上下颠倒数次进行简单混匀。

•常规转染步骤我们强烈推荐您针对每个细胞系建立优化转染条件。

miR-19通过靶定PDE4A促进肝癌细胞增殖

miR-19通过靶定PDE4A促进肝癌细胞增殖

miR-19通过靶定PDE4A促进肝癌细胞增殖袁丽杰;曲艺林;刘兴汉;赵恒宇【摘要】目的:探讨miR-19对肝癌细胞系MHCC97H和LM3增殖的影响和肿癌组织中的表达情况,以及确定其靶基因和功能.方法:Real-time PCR检测miR-19的表达.WST-1和PI染色分析MHCC97H和LM3细胞的增殖水平.生物信息学预测、Luciferase以及Real-time PCR和western blot验证miR-19下游靶基因.结果:miR-19在肝癌组织中表达下调(P<0.01).miR-19可以抑制肝癌细胞系MHCC97H和LM3增殖能力.PDE4A作为miR-19的候选靶基因,其通过诱导PDE4A上调促进肝癌细胞增殖.结论:miR-19的直接靶基因是PDE4A,下调miR-19促进PDE4A的表达,进而促进肝癌细胞的增殖.【期刊名称】《黑龙江医药》【年(卷),期】2016(029)006【总页数】4页(P1041-1044)【关键词】微小RNA;肝癌;增殖;PDE4A【作者】袁丽杰;曲艺林;刘兴汉;赵恒宇【作者单位】哈尔滨医科大学大庆校区;哈尔滨医科大学大庆校区;哈尔滨医科大学大庆校区;大庆油田总医院黑龙江大庆163319【正文语种】中文【中图分类】R735.7肝细胞性肝癌(hepatocellular carcinoma,HCC)在我国占原发性肝癌的90%[1]。

肿瘤在全球每年新增病例中位列所有肿瘤新增病例的第5位,全球死亡病例位列第2位,其中男性偏多[2]。

HCC的恶性度高,疾病发生发展迅速,预后效果差。

肝癌的临床早期诊断比较艰难,异质性增强导致了生物学行为多样性,临床目前主要依靠影像学和血清甲胎蛋白AFP测定来检测肝癌,但影像学检查对早期体积较小的肝癌判断能力较弱,导致诊断延误[3],同时AFP同样存在诊断敏感度的问题[4],因而肝癌首诊时约有70%的患者已经属于中晚期[5],因此寻找早期肝癌标志物是肝癌临床诊断亟待解决的临床问题。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

FuGENE ®HD Transfection Reagent1.What this Product DoesNumber of Transfection ExperimentsIn a typical experiment using HeLa or COS-1 cells, 1 ml of FuGENE ®HD Transfection Reagent can be used to perform up to three hundred transfections in 35-mm tissue-culture dishes, using 3 ␮l of reagent combined with 1 – 2 ␮g DNA per well. This is equivalent to over 6,000wells in a 96-well plate or 1,000 wells in a 24-well plate.L Optimal expression depends upon experimental conditions includ-ing cell type, passage history, confluence, seeding protocol, com-plex incubation time, serum batch, etc. The above amounts of reagents work well with HeLa or COS-1 cells. In other test systems,two- to three-fold higher amounts of reagent yield optimal levels of expression.FormulationFuGENE ® HD Transfection Reagent is a proprietary blend of lipids and other components supplied in 80% ethanol, sterile-filtered, and pack-aged in glass vials. It does not contain any ingredients of human or animal origin.Storage and Stability•FuGENE ® HD Transfection Reagent is shipped at +15 to +25°C.•Store FuGENE ® HD Transfection Reagent at +2 to +8°C, with the lid very tightly closed. The reagent is stable through the expiration date printed on the label when stored under these conditions.L FuGENE ® HD Transfection Reagent remains fully functional evenafter repeatedly opening the vial (at least five times over a two-month period) as long as the vial is tightly recapped and stored at +2 to +8°C between uses.L Do not store FuGENE ® HD Transfection Reagent below 0°C.Components may precipitate and alter results. If you accidently place the reagent at Ϫ20°C, briefly warm it to 37°C to dissolve any precipitate. It should function normally; however, do not return it to the freezer.Special HandlingN Always bring to room temperature and mix FuGENE ® HD Transfec-tion Reagent prior to use (vortex for one second or use inversion).N Do not aliquot FuGENE ® HD Transfection Reagent from the originalglass vials. Chemical residues in plastic vials can significantly decrease the biological activity of the reagent. Minimize the contact of undiluted FuGENE ® HD Transfection Reagent with plastic sur-faces.N Always dilute the reagent by pipetting directlyinto serum-free medium. Do not allow the FuGENE ® HD Transfection Reagent to contact the plastic walls of the tube containing the serum-free medium during the dilution step.N Do not use siliconized pipette tips or tubes.Additional Equipment and Reagents RequiredAdditional reagents and equipment required to perform transfection assays using FuGENE ® HD Transfection Reagent, but not provided,include:General Laboratory Equipment•standard cell culture equipment (e.g., biohazard hoods, incubators,microscope)•standard pipetters and micropipetters •vortex mixerFor Plasmid Preparation•purified plasmid stock (0.1 ␮g/␮l – 2.0 ␮g/␮l) in sterile TE (10 mM Tris, 1 mM EDTA, pH 8.0) buffer or sterile water•Genopure Plasmid Midi Kit*, Genopure Plasmid Maxi Kit*, or High Pure Plasmid Isolation Kit* can be used to prepare plasmid.For Verification of Vector Function •assay appropriate for transfected gene•G-418* or Hygromycin B* (optional; for stable transfection experi-ments)For Transfection-Complex Formation•Opti-MEM I Reduced Serum Medium, water, or serum-free medium •24-well plate to serve as test tube rack for FuGENE ® HD Transfec-tion Reagent vial•sterile polystyrene tubes or round-bottom 96-well platesCells Growing in Log Phase•select subconfluent cultures in log phase for preparation of the cell cultures for transfection•method to quantify cell number to reproducibly plate the same number of cellsApplicationFuGENE ® HD Transfection Reagent is a multi-component reagent that forms a complex with DNA, then transports the complex into animal or insect cells. Benefits of FuGENE ® HD Transfection Reagent include:•High transfection efficiency in many common cell types, including HeLa, NIH/3T3, COS-1, COS-7, CHO-K1, Hep G2, HEK-293, MCF7,and some insect cell lines. In addition, you will achieve excellent transfection efficiency in some cell lines (e.g., RAW) that are not transfected well by other reagents. Detailed transfection protocols and sample results are available at .•Demonstrates minimal cytotoxicity or changes in morphology when adequate numbers of cells are transfected, and eliminates the requirement to change media after the addition of transfection complex.•Suitable for transient and stable transfection.•Functions exceptionally well in the presence or absence of serum;eliminates the need to change media.To ensure the quality of cells to be transfected, Roche recommends using freshly-obtained, low-passage cell sines form ATCC ®. For more information please visit and bookmark .For the transient and stable transfection of animal and insect cellsCat. No. 04 709 691 0010.4 ml (up to 120 transfections)Version November 2007Cat. No. 04 709 705 001 1 ml (up to 300 transfections)Store at +2 to +8°CCat. No. 04 709 713 001 1)Mega-pack 5 × 1 ml (up to 1,500 transfections)Cat. No. 05 061 369 00110 ml (up to 3,000 transfections)Cat. No. 04 883 560 001Trial-pack1)The five vials are packaged together in one box with one pack insertFor life science research only. Not for use in diagnostic procedures. FOR IN VITRO USE ONLY.2.How to Use this Product2.1Before you BeginRequired Amount of FuGENE® HD Transfection ReagentFor initial optimization experiments, transfect a monolayer of cells that is 80 – 90% confluent in a six-well culture dish, using 3:2, 4:2, 5:2, 6:2, 7:2, and 8:2 ratios of FuGENE® HD Transfection Reagent (␮l) to DNA (␮g), respectively. For most cell types, these FuGENE® HD Transfection Reagent:DNA ratios provide excellent transfection levels.L Subsequent optimization may further increase efficiency in your particular application. In addition to varying the volume of FuGENE® HD Transfection Reagent, other parameters may be evaluated (see section 2.6, Parameters for Optimization, and sec-tion 3, Troubleshooting).Plasmid DNA•It is critical to accurately determine the plasmid DNA concentration using 260-nm absorption (estimates of DNA content based on the intensity of gel bands are not sufficiently accurate). Determine the DNA purity using a 260 nm/280 nm ratio; the optimal ratio is 1.8.•Prepare the plasmid DNA solution in sterile TE (Tris/EDTA) buffer or sterile water at a concentration between 0.1 ␮g/␮l and 2.0 ␮g/␮l. Cell Culture ConditionsMinimize both intra- and inter-experimental variance in transfection efficiency by using cells that are regularly passaged, proliferating well (best when in a log-growth phase), and plated at a consistent den-sity. FuGENE® HD Transfection Reagent is different from FuGENE® 6 Transfection Reagent regarding the optimal density of cells required for maximal expression with minimal negative effect; FuGENE®6 Transfection Reagent is formulated to work at low cell densities, whereas FuGENE® HD Transfection Reagent is formulated to work at higher cell densities. Cells must be healthy and free of mycoplasma and other contaminants.L If you have used FuGENE® 6 Transfection Reagent in the past, we suggest that you increase the plating density for initial tests using FuGENE® HD Transfection Reagent. For most cell lines, use the reagent at cell-plating densities at least twice that used with FuGENE® 6 Transfection Reagent to yield maximum protein expression. For most cell lines, cultures should be 80 – 90% con-fluent at the time of transfection. For contact-inhibited cell lines such as NIH/3T3, optimal results are obtained when cells are plated at lower densities.Other Media AdditivesIn some cell types, antimicrobial agents (e.g., antibiotics and fungicides) that are commonly included in cell-culture media may adversely affect the transfection efficiency of FuGENE® HD Transfection Reagent. If possible, exclude additives for initial experi-ments. Once high-efficiency conditions have been established, these components can be added back while monitoring your transfection results. Cell growth and/or transfection efficiency may be affected by variations in sera quality or media formulations.Verification of Vector FunctionOptimize transfection conditions with a known positive-control reporter gene construct prior to transfecting cells with a new vector construct:•Determine transfection efficiency with a reporter gene assay (CAT*,␤-Gal*, Luciferase*, SEAP*, or hGH*).•Sequence across the flanking vector insert regions to verify the integrity of your new construct.2.2Preparation of Cells for Transfection2.3Overview of Initial Transfection ExperimentAdherent and Suspension Cells in a Six-well Plate or 35-mm Culture DishFor initial optimization, test FuGENE® HD Transfection Reagent:DNA ratios of 3:2, 4:2, 5:2, 6:2, 7:2, and 8:2 (␮l for FuGENE® HD Transfection Reagent, and ␮g for DNA, respectively). The preparation of the com-plex for a single well of a six-well plate, or a 35-mm culture dish, is described in section 2.4. These ratios will function very well for com-monly used adherent cells and suspension cells. For your particular cell line and culture conditions you may find that ratios of 9:2, 10:2, 11:2, or 12:2 result in even greater expression. Try these ratios if you find the highest expression levels in the 8:2 ratio well.N Prepare the transfection complex in diluent that does not contain serum (e.g., Opti-MEM I Reduced Serum Medium), even if the cells are transfected in the presence of serum. For some cell lines, the complex may be formed in DMEM or sterile water.L For additional optimization tips, see section 2.6 and visit /fugene/hdRatio OverviewPreparation of a transfection complex that is sufficient for a 35-mm culture dish, or one well of a six-well plate, at six different ratios: Tab. 1: Preparation of transfection complex for a 35-mm culture dish.Cell Type ProcedureAdherentcellsOne day before the transfection experiment, trypsinizethe monolayer, adjust cell concentration, and plate thecells in the chosen cell-culture vessel. For most celltypes, plating 3 – 6 × 105 cells in 2 ml of medium in a35-mm culture dish (or six-well plate) overnight willachieve the desired density of Ͼ80% confluency atthe time of transfection. For cell lines with specialcharacteristics, such as contact-inhibited NIH/3T3cells, a lower plating density should be used. If usingculture plates of a different size, adjust the total num-ber of cells, starting volume of FuGENE® HD Transfec-tion Reagent, and the starting mass of DNA inproportion to the relative surface area (Table 2). SuspensioncellsUse freshly passaged cells at a concentration of 5×105/ml to 1 × 106/ml in 2 ml of medium in a 35-mmculture dish (or six-well plate). If using culture platesof a different size, adjust the total number of cells,starting volume of FuGENE® HD TransfectionReagent, and the starting mass of DNA in proportionto the relative volume (Table 2).Tubelabel(ratio)Diluent(␮l)FuGENE® HDTransfectionReagent (␮l)DNA(␮g)Comments3:210032Add the entire volume toa 35-mm culture dish oreach well of a six-wellplate, or 2 – 15 ␮l to eachwell of a 96-well plate.Suggested volumes fordifferent culture vesselsare included in Table 2. 4:2100425:2100526:2100627:2100728:2100822.4Transfection ProcedureNotes:L As with any experiment, include appropriate controls. Preparewells with cells that remain untransfected, cells with transfection reagent alone, and cells with DNA alone.L For stable transfection experiments, the complex-containingmedium should be left unchanged until the cells need to be pas-saged. At that time, include the appropriate selection antibiotics (G 418* or Hygromycin B*).L To prepare transfection complexes for different-sized containers orparallel experiments, proportionally change the quantity of all components according to the total surface area of the cell culture vessel being used (Table 2).L For ease-of-use when transfecting small volumes, as in 96-wellplates containing 0.1 ml culture medium per well, prepare 100 ␮l of transfection complex and add 2 – 15 ␮l to each well depending upon the cell type.L The optimal ratio of transfection reagent:DNA and the optimaltotal amount of complex may vary with cell line, cell density, day of assay, and gene expressed.L After performing the optimization experiment where several ratioswere tested, select a ratio in the middle of the plateau for future experiments.2.5Cotransfection ExperimentsSuggestionsFor cotransfection experiments with FuGENE ® HD Transfection Reagent, maintain the same total reagent:total DNA ratio as that used for a single plasmid in your system. Thus, the total amount of the plas-mid DNA should be equal to the amount of plasmid used in a single plasmid transfection.ᕡAllow FuGENE ® HD Transfection Reagent, DNA, anddiluent to adjust to +15 to +25°C. Vortex for one second or invert the FuGENE ® HD Transfection Reagent vial to mix.ᕢDilute DNA with appropriate diluent, for example, Opti-MEM IReduced Serum Medium, serum-free medium (without anti-biotics or fungicides), or sterile water to a concentration of 2␮g plasmid DNA/100 ␮l Opti-MEM (0.02␮g/␮l).L For insect cells, use sterile water as diluent. For other celllines, try sterile water or serum-free medium as an alterna-tive diluent.ᕣPlace 100 ␮l diluent, containing 2 ␮g DNA into each of six ster-ile tubes labeled 3:2, 4:2, 5:2, 6:2, 7:2, and 8:2.Recommendation : Use sterile polystyrene tubes or round-bottom, 96-well plates to form the transfection complex.L Due to manufacturer variability with release agents for96well plates, we suggest using tissue culture treated 96well plates to reduce variablity.ᕤForm the transfection complex by adding FuGENE ® HDTransfection Reagent to tubes containing diluted DNA :Pipet the FuGENE ® HD Transfection Reagent (3, 4, 5, 6, 7, or 8␮l) directly into the medium containing the diluted DNA with-out allowing contact with the walls of the plastic tubes.N To avoid adversely affecting transfection efficiency, do notallow undiluted FuGENE ® HD Transfection Reagent to come into contact with plastic surfaces (such as the walls of the tube that contains the serum-free medium) other than pipette tips. Do not use siliconized pipette tips or tubes.ᕥMix and incubate the transfection complex :Vigorously tap the tube or vortex for one to two seconds to mix the contents. If using a 96-well plate, place the plate on a rotat-ing shaker for 5 – 10 seconds. Incubate the transfection reagent:DNA complex for 15 minutes at room temperature.For some ratios and cell types, incubation is not necessary for optimal complex formation, while a longer incubation time is better for other cell types. Determine this for your particular cell line and the ratio you use.ᕦAdd the transfection complex to cell s:Remove culture vessel from the incubator. Removal of growth medium is not necessary. Add the transfection complex to the cells in a drop-wise manner or add below the surface of the medium. Swirl the wells or flasks to ensure distribution over the entire plate surface. Use of a rotating platform shaker for 30 seconds at low speed provides adequate mixing for 96-well plates.Once the FuGENE ® HD Transfection Reagent:DNA complex has been added to the cells, there is no need to remove and replace with fresh medium (as is necessary with some other transfection reagents).L In our experience, the exposure of most common laboratorycell types (COS-1, CHO-K1, HEK-293, HeLa, Hep G2, MCF-7) to the transfection complex until performance of the gene expression assay (24–48 hours later) does not affect the results. If you desire to transfect cells that are in serum-free medium during the transfection process, then replace the medium with serum-containing medium 3 – 8 hours after transfection, unless the cells normally grow in serum-free medium. ᕧIncubate cells and assay the results :Following transfection, incubate the cells for 18 – 72 hours prior to measuring protein expression. The length of incubation depends upon the transfected vector construct, the cell type being transfected, the cell medium, cell density, and the type of protein being expressed. After this incubation period, measure protein expression using an assay that is appropriate for your system.L If you observe low transfection levels or more than10 – 30% cell death, refer to section 3, Troubleshooting and /fugene/hd2.6Parameters for Optimization2.7Transfection of Adherent Cells Adapted for Suspension Growth•In some cases, adherent cells may be adapted for suspension growth, thus enabling the production of transiently transfected cells on a very large scale.•HEK-293 cells grown in suspension in serum-free medium that did not contain heparin or dextran sulfate produced significant amounts of protein following transfection.2.8Guidelines for Preparing FuGENE® HD Transfection Reagent:DNA Complex for Various Culture Vessel SizesThe starting volume and mass to add to the different culture vessels is based upon preparing a 100-␮l transfection complex as described in sec-tions 2.3 and 2.4. For best results, prepare a 100-␮l complex at different ratios and add varying amounts of each ratio when optimizing. The amounts below are based on the 100-␮l complex as prepared in sections 2.3 and 2.4.Suggested seeding density for adherent cells = 30,000 – 70,000 cells per cm2Suggested seeding density for suspension cells = 250,000 – 500,000 cells per mlTab. 2: Refer to the table below when setting up your transfection reac-tions. T hese are suggested seeding densities and are media, passage level, laboratory, and cell-line dependent. It is critical that log phase cultures are selected for subculture for the transfection experiments, and that cultures are seeded at the proper density for the transfection experiment. Observe cultures and plate them so that the monolayer is 80–90% confluent at the time of trans-fection. This must be determined empirically. For some cell lines, 60–80% con-fluency is sufficient. However, a contact-inhibited cell line, such as NIH/3T3, should be plated at lower confluence due to its growth characteristics.1) Scale up total volume for larger vessels.3.TroubleshootingParameter to beoptimizedProcedureFuGENE® HD Transfection Reagent:DNA ratio Form the transfection complex at several ratios: 3:2, 4:2, 5:2, 6:2, 7:2, 8:2, 10:2, and 12:2 (␮l FuGENE® HD Transfec-tion Reagent: ␮g DNA).In some systems, altering the ratio of FuGENE® HD Transfection Reagent to DNA can increase the level of protein expression.L It has been reported that for some plasmid preparations, a ratio of 2:2 yielded optimal results. This is unusual and may reflect some property of the plasmid preparation rather than a characteristic of the FuGENE® HD Transfec-tion Reagent.Amount of transfectioncomplex addedTry adding 200%, 150%, 75%, 50%, and 25% of the amount of 100-␮l transfection complex suggested in Table 2.Number of cells plated Plating more cells will overcome negative growth effects of excess transfection complex. For cells with special growth characteristics, such as NIH/3T3 cells, do not use this as the first parameter for optimization.Incubation time for the transfection complex to form Vary the length of incubation time for transfection-complex formation: add the complex to the cells immediately after the components are combined and mixed, and then at several intervals up to 40 minutes (i.e., 0, 15, 25, and 40 min-utes). We have observed that in some cell lines, the transfection-complex incubation time tends to have no effect on results when using higher ratios; however, results using lower-ratio-complexes varied depending on the incubation time for complex formation.Special tips for sensitive cell lines •Reduce the time of exposure to the transfection complex (2–3 hours maximum), then replace the medium.•Use the lower ratios, and allow the complex to form for a longer period of time (determine empirically for your cell line), then add lower amounts of the complex (50% or less of what was originally tested).Culture vessel Surfacearea(cm2)TotalvolumeofmediumSuggested seeding densitySuggested amount ofthe 100-␮l trans-fection complex toadd to each well (␮l)Final amount of FuGENE® HDTransfection Reagent (␮l) ineach well following addition ofsuggested amount of 100-␮ltransfection complexCells/wellAdherent cellsCells/wellSmall or suspensioncellsUsing the3:2 ratioUsing the8:2 ratio totalvolumevolume forlargerlow high low high96-well plate(1 well)0.30.110,00020,00025,00050,00050.150.424-well plate(1 well)1.90.550,000125,000250,000500,000250.752.012-well plate(1 well)3.8 1.0100,000250,000375,000750,00050 1.54.0 35-mm dish82200,000500,000500,0001,000,000100 3.08.06-well plate(1 well)9.42200,000600,000500,0001,000,000100 3.08.0 60-mm dish215500,0001,400,0001,250,0002,500,000250 1)7.520.0 10-cm dish55101,500,0003,500,0002,500,0005,000,000500 1)15.040.0 T-25 flask256700,0001,700,0001,500,0003,000,000300 1)9.024.0 T-75 flask75202,000,0005,000,0005,000,00010,000,000900 1)27.072.0Low trans-fection efficiency Poor quality orinsufficient quantityof nucleic acidsVerify the amount, purity, and sequence of nucleic acid.Perform a control transfection experiment with a commercially available transfection-grade plasmidpreparation.Chemical contaminants may be in the plasmid preparation. Avoid phosphate buffers until you havetested them in your system.L Endotoxins are reported to be cytotoxic to some very sensitive cell lines.Insufficient numberof cellsUse adherent cells that are at least 80% confluent. Low cell density results in fewer cells available totake up transfection complex, and excess complex may be cytotoxic; in addition, fewer cells yieldless protein.Too many cells orcells post log phaseWhen confluent cultures are subcultured, or cells are plated at too high a density, the cells fail to dividein the culture being transfected. This results in suboptimal expression.Suboptimal FuGENE®HD TransfectionReagent:DNA ratio,complex incubationtime, total amount oftransfection complexadded, or cell densityOptimize the FuGENE® HD Transfection Reagent:DNA ratio, complex incubation time, amount ofcomplex added to cells, and cell density, according to the following procedure:Day before transfection:Prepare two 96-well plates of cells at high and low seeding densities (see Table 2 for suggestions).Day of transfection:•Form 200 ␮l of transfection complex at ratios of 2:2, 3:2, 4:2, 5:2, 6:2. 7:2, and 8:2 (␮l transfectionreagent:␮g DNA) following the protocol in this pack insert (sections 2.3, 2.4) and doubling theamounts of all components.•As soon as the complexes are combined and mixed, add 10, 5, or 2.5 ␮l of each complex to one of3columns of cells in each 96-well plate (i.e., columns 2, 3, and 4). Leave all outer wells empty ascontrols.•Continue to incubate the complexes at room temperature. After an additional 10 – 15 minutes, add 10,5, or 2.5 ␮l of each complex to the next 3 columns (5, 6, and 7) of cells in each 96-well plate.•Continue to incubate the complexes at room temperature. After an additional 10 – 15 minutes, add 10,5, or 2.5 ␮l of each complex to the next 3 columns (8, 9, and 10) of cells in each 96-well plate.•Assay the plates 1–2 days later. Select the ratio, amount of complex, and time of transfection-complexincubation that resulted in optimal expression.•If optimal transfection occurs at the higher ratios, repeat this process using ratios of 6:2, 7:2, 8:2, 10:2,12:2, and 14:2. Add 5, 10, and 15 ␮l of complex. We have never successfully transfected cells using theratio of 2:2, but it has been reported that some plasmid preparations transfect at this ratio.See section 2.6, Optimization of FuGENE® HD Transfection Reagent:DNA ratio, for more information andvisit /fugene/hdFuGENE® HD Trans-fection Reagent wasaliquotedCheck that FuGENE® HD Transfection Reagent is stored in the original container. If the reagent wasaliquoted into plastic containers, there is a high chance of inactivation. Make sure the reagent isimmediately mixed with the dilute DNA either by vortexing or pipetting up to 10 – 15 times.FuGENE® HD Trans-fection Reagent cameinto contact withplastic or wasinadequately mixedRepeat transfection, carefully pipetting FuGENE® HD Transfection Reagent directly into the serum-freemedium, being careful not to touch the sides of the container while adding the FuGENE® HD Transfec-tion Reagent to the diluted DNA. If the FuGENE® HD Transfection Reagent is added too gently, it maylayer on top of the medium, thus making contact with the plastic.Transfection complexwas formed in serum-containing mediumCheck original bottle of medium used for complex formation. Repeat experiment using new bottle ofOpti-MEM that does not contain any additives (e.g., serum, antibiotics, growth enhancers, heparin,dextran sulfate, etc.). Try forming the complex in sterile water or plain DMEM.Media and mediacomponentsDifferent media and media components may influence the level of transfection efficiency andsubsequent growth of the transfected cells, as well as expression of the recombinant protein. Some lotsof sera have been reported to interfere with optimal transfection.Quality and/or lot-to-lot differences that affect transfection experiments have been noted in both seraand media. Check that the medium and/or serum is from the same lot that worked previously. Try newlots or a different vendor.Culture may becontaminated withmycoplasmaCultures contaminated with mycoplasma have been shown to have decreased transfection efficacy.Determine if culture is contaminated with mycoplasma; use the Mycoplasma Detection Kit* orMycoplasma PCR ELISA* to assess contamination.Inconsistent results Ratio or amount oftransfection complexis at the edge ofperformance plateauInitial experiments should be completed to determine the ratios, amount of complex to be added, andlength of time for complex formation for optimal performance. In our experience, we have found the pla-teau to be relatively broad. We recommend that future experiments be performed with ratios, incubationtime, and amounts of complex that were in the middle of the plateau. If conditions are selected at theedge of the plateau, very small procedural differences may cause large differences in the resulting pro-tein expression. Increased consistency may be achieved by shifting parameters away from the edge ofthe plateau to the middle of the plateau.Transfection complexformation:timing,amounts, and ratioFormation of the complex involves a multifaceted interaction between the transfection reagent and DNAas well as biological parameters. Differences in any of the components or techniques may result ininconsistencies. If results do not meet your expectations, then repeat the optimization experimentselecting areas near the plateau found in previous experiments. For current experiments, determine ifyou should use a different ratio, length of time, or amount of complex for more consistent transfectionresults.Extensive testing of the FuGENE® HD Transfection Reagent is performed on two cell lines: one easy totransfect and one very difficult to transfect. All reagent lots must pass this rigorous testing before wemake it available to you. However, we cannot test all cell lines, media, sera, and vectors; in your labora-tory, you may find slight differences in the optimal ratio, amount of complex, or time for complex forma-tion for some lots of FuGENE® HD Transfection Reagent.Cells For consistent results, cells must be properly maintained. Cells change with passage level, passage conditions, media, and sera. For some cell lines, these changes have little to no effect on transfectionexperiments, but for other cell lines, these changes have profound effects. Each cell type may have a dif-ferent optimal transfection condition. Optimal values for a single cell type may also change slightly withvector construct and type of protein expressed.Observation Possible cause RecommendationSigns of cytotoxicity Transfected protein iscytotoxic or isproduced at highlevelsReduced viability or slow growth rates may be the result of high levels of protein expression, as the cell’smetabolic resources are directed toward production of the heterologous protein. The expressed proteinmay also be toxic to the cell at the level expressed.To analyze cytotoxicity, prepare experimental controls as described below.Prepare extra control wells containing:ቢ Cells that are not transfectedባ Cells treated with DNA alone (e.g., without FuGENE® HD Transfection Reagent)ቤ Cells treated with FuGENE® HD Transfection Reagent alone (no DNA added)ብ Cells transfected with a non-toxic or secreted protein.Compare experimental transfected cells to cells in the control wells (described above). Considerrepeating the experiment with a secreted reporter gene such as SEAP, hGH, or a standard ␤-gal controlvector. Cells expressing SEAP should show little to no evidence of cytotoxicity.Too much transfec-tion complex fornumber of cellsIncrease the number of cells plated, and/or decrease the total amount of complex added to the cells. Trydifferent ratios and allow the complexes to form for different time intervals. Add different amounts ofcomplex; for example, make the complex as usual but add 75%, 50%, or 25% of the usual amounts toeach well. See Suboptimal FuGENE® HD:DNA Ratio in "Low transfection efficiency" section of this tablefor details or optimization protocol.Culture may becontaminated withmycoplasmaDetermine if culture is contaminated with mycoplasma; use the Mycoplasma Detection Kit* orMycoplasma PCR ELISA* to assess contamination.Cells may not behealthyAssess physiological state of cells and the incubation conditions (e.g., check incubator CO2, humidity,and temperature levels). Observe cells prior to each passage for morphology and absence of contami-nants. Make sure cells do not overgrow. Routinely passage cells prior to reaching confluency. Make surethat culture media and additives are within expiration date and have been stored properly.Diluent is toxic to thecellsDMEM is toxic to some insect cell lines. For these cells, prepare the transfection complex in sterilewater. You may also try forming the complex in the medium in which the cells are growing, providingthat the medium does not contain serum, heparin, or dextran sulfate.Plasmid preparationcontaminated withendotoxinEndotoxin is reported to be cytotoxic to sensitive cell lines.If above tests provenegative, FuGENE®HD TransfectionReagent may not beoptimal for your cells.Try FuGENE® 6 Transfection Reagent*, DOTAP Liposomal Transfection Reagent*, DOSPER LiposomalTransfection Reagent*, or X-tremeGENE Q2 Transfection Reagent*.High protein-expression levelsHigh expression levels of certain intracellular proteins (e.g., Green Fluorescent Protein [GFP]) may becytotoxic to some cell types. Cell proliferation, toxicity, and cell death may be monitored using Apoptosisand Cell Proliferation products from Roche Applied Science (visit /apoptosis for more information).Media and mediacomponentsTest different media and optimize the level of each medium component for these cytotoxic effects.Although it is not usually necessary to remove the transfection complex following the transfection step,it may be necessary to feed your cells with fresh media for extended growth periods. This is particularlyimportant if the transfected cells are allowed to continue to grow for 3 – 7 days to provide maximalprotein expression.。

相关文档
最新文档